a substance that when introduced to the body produces a biologicaleffect for an intended purpose
what are drugs used for, and the exception
to treat symptoms of condition, notthe cause of disease (exception is antimicrobial drugs) or to preventacondition (anti-HIV drugs to reduce risk)
antimicrobial drugs
target the cause of infection rather than symtoms
what are the 2 broad groups of drugs
small molecules and biologics
small molecules administration
orally e.g paracetamol
biologics administration
to big to orally, subcutaneously administer e.g AA peptides
types of drug name
chemical, generic, brand/trade name
chemical name
for chemists, describes the chemical structure of drug
generic name
for pharmacologists, stems/roots to indicate origins, use, action or structure of drugs
brand/trade name
for general public, invented by drug companies for marketing purpose, different depending on manufacturer and country
PK
pharmacokinetics, what the body does to a drug
4 key principles of PK
Absorption, distribution, metabolism, excretion
major PK associated organs
intestine, liver, kidneys
organs with barrier function
brain, placenta
brain transporters function
barrier, influx transporters expressed at barrier to remove drugs to don't cause harm
placenta transporters function
minimise harmful toxins and protect developing foetus
what plasma-cone time curve tells us
dose, frequency of drug administration, drug toxicity
2 routes of administration
most common oral administration or intravenous
Cmax
peak plasma concentration
Tmax
time required to achieve Cmax
therapeutic window
a concentration range bound by MEC lower end and MTC at upper end
Minimum toxic concentration (MTC)
concentration that produces unacceptable effects or where no further benefit observed
minimum effective concentration (MEC)
minimum for drug to produce desired effects
duration of action of drug
time when concentration is in therapeutic window
AUC of drug
gives idea of total exposure of body to drug
drug absorption
process by which a drug moves from its site of administration to systemic circulation
body compartmentalisation
drugs need to cross lipid membrane to move from one compartment to another, depends on physical and chemical components of the drug
2 mechanisms for drugs moving across membrane
transcellular (move across cell) and paracellular (through tight junctions)
drugs that move across cell membrane and how
lipophilic drugs via passive or facilitated diffusion (carrier proteins)
drugs that move through tight junctions
low molecular weight and hydrophilic drugs
physicochemical properties of drug that affect oral absorption
molecular size, solubility, ionisation
how molecular size effects oral absorption
decreases as molecular weight increase (to large can't)
how solubility affect oral absorption
hydrophilicity and lipophilicity affect passive diffusion at membrane
very lipophilic drugs
get stuck in cell lipid membrane and distributed into adipose tissue
lipophilic drugs absorption
can cross membrane, reach other side of blood brain barrier
how ionisation effect drug absorption
if ionised molecule cant cross lipid membrane passively, move compartments. degree of ionisation changes depending on pH environment
ionisation of drugs
many drugs classed as weak acids/bases results in pH dependent ionisation of functional groups
pKa
pH at which drug molecules are 50% ionised
biological factors that affect oral absorption
pH, ingested food, gut mobility (fat/protein slow down absorption decrease conc in blood), intestinal enzymes, transporters
activated charcoal
orally administered, has holes on surface that bind drug molecule then molecules are not absorbed and removed in faeces. given if early detection of drug overdose